Get started
Author

Gough G. Au

Mitochondrial DNA neutrophil extracellular traps are formed after trauma and subsequent surgery
2014 · Daniel J. McIlroy, Andrew G. Jarnicki, et al. · Journal of Critical Care · 185
PDF
Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection
2021 · Ryan J. Farr, Christina L. Rootes, et al. · PLoS Pathogens · 168
PDF
Systemic Therapy of Malignant Human Melanoma Tumors by a Common Cold-Producing Enterovirus, Coxsackievirus A21
2004 · Darren R. Shafren, Gough G. Au, et al. · Clinical Cancer Research · 154
Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder Cancer
2019 · Nicola E. Annels, David Mansfield, et al. · Clinical Cancer Research · 122
PDF
Oncolytic Coxsackievirus A21 as a novel therapy for multiple myeloma
2007 · Gough G. Au, Lisa F. Lincz, et al. · British Journal of Haematology · 99
Oncolysis of vascular malignant human melanoma tumors by Coxsackievirus A21
2005 · Gough Au, A. Lindberg, et al. · International Journal of Oncology · 83
Experimental and in silico evidence suggests vaccines are unlikely to be affected by D614G mutation in SARS-CoV-2 spike protein
2020 · Alexander J. McAuley, Michael J. Kuiper, et al. · npj Vaccines · 70
PDF
Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus
2018 · Nicola E. Annels, Mehreen Arif, et al. · Molecular Therapy — Oncolytics · 64
PDF
ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets
2021 · Glenn A. Marsh, Alexander J. McAuley, et al. · npj Vaccines · 53
PDF
Cellular receptor interactions of C-cluster human group A coxsackieviruses
2003 · Nicole G. Newcombe, Per Andersson, et al. · Journal of General Virology · 52
Potent Oncolytic activity of human enteroviruses against human prostate cancer
2008 · Linda J. Berry, Gough G. Au, et al. · The Prostate · 46
Quantitative phosphoproteomics uncovers synergy between DNA-PK and FLT3 inhibitors in acute myeloid leukaemia
2020 · Heather C. Murray, Anoop K. Enjeti, et al. · Leukemia · 43
PDF
Localisation of tachykinin NK1 and NK3 receptors in the human prefrontal and visual cortex
2000 · Paul A Tooney, Gough G Au, et al. · Neuroscience Letters · 39
Metabolic Profiling from an Asymptomatic Ferret Model of SARS-CoV-2 Infection
2021 · David J. Beale, Rohan Shah, et al. · Metabolites · 36
PDF
Oncolysis of malignant human melanoma tumors by Coxsackieviruses A13, A15 and A18
2011 · Gough G Au, Leone G Beagley, et al. · Virology Journal · 36
PDF
Inhibition of extracellular matrix mediated TGF-β signalling suppresses endometrial cancer metastasis
2017 · Subhransu S. Sahoo, Min Yuan Quah, et al. · Oncotarget · 28
PDF
Tachykinin NK1 and NK3 Receptors In The Prefrontal Cortex Of The Human Brain
2000 · Paul A Tooney, Gough G Au, et al. · Clinical and Experimental Pharmacology and Physiology · 27
Regional administration of oncolytic Echovirus 1 as a novel therapy for the peritoneal dissemination of gastric cancer
2009 · Erin S. Haley, Gough G. Au, et al. · Journal of Molecular Medicine · 25
The swan genome and transcriptome, it is not all black and white
2023 · Anjana C. Karawita, Yuanyuan Cheng, et al. · Genome biology · 23
PDF
Characterisation and natural progression of SARS-CoV-2 infection in ferrets
2022 · Gough G. Au, Glenn A. Marsh, et al. · Scientific Reports · 23
PDF
Antagonism of STAT3 signalling by Ebola virus
2021 · Angela R. Harrison, Shawn Todd, et al. · PLoS Pathogens · 16
PDF
Enterovirus Capsid Interactions with Decay-Accelerating Factor Mediate Lytic Cell Infection
2004 · Nicole G. Newcombe, E. Susanne Johansson, et al. · Journal of Virology · 16
Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies isolated from a BNT162b2-vaccinated SARS survivor
2023 · Wan Ni Chia, Chee Wah Tan, et al. · Science Advances · 13
PDF
In vitro characterisation of SARS‐CoV‐2 and susceptibility of domestic ferrets ( Mustela putorius furo )
2021 · Glenn A. Marsh, Alexander J. McAuley, et al. · Transboundary and Emerging Diseases · 12
PDF
Combination of a novel oncolytic immunotherapeutic agent, CAVATAK (coxsackievirus A21) and immune-checkpoint blockade significantly reduces tumor growth and improves survival in an immune competent mouse melanoma model
2014 · Darren Shafren, Min Quah, et al. · Journal for ImmunoTherapy of Cancer · 12
PDF
Works count: 72
Citation count: 1,522
H-index: 20
I10-index: 26
Year
Topic
Type